We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$56.6B
AUM Growth
+$810M
Cap. Flow
-$1.48B
Cap. Flow %
-2.61%
Top 10 Hldgs %
13.48%
Holding
2,531
New
387
Increased
823
Reduced
1,010
Closed
163

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$94.6M
2
AMAT icon
Applied Materials
AMAT
+$91.8M
3
ANET icon
Arista Networks
ANET
+$73.5M
4
ILMN icon
Illumina
ILMN
+$50.4M
5
TV icon
Televisa
TV
+$49.9M

Top Sells

Rank Stock Value
1
MRO
Marathon Oil Corporation
MRO
+$149M
2
DLTR icon
Dollar Tree
DLTR
+$140M
3
INTC icon
Intel
INTC
+$129M
4
NVDA icon
NVIDIA
NVDA
+$104M
5
NLSN
Nielsen Holdings plc
NLSN
+$84.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.88%
2 Financials 15.63%
3 Technology 12.66%
4 Energy 10.4%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSEX icon
2226
Middlesex Water
MSEX
$1.05B
$11K ﹤0.01%
+277
New +$11.9K
PLAY icon
2227
Dave & Buster's
PLAY
$343M
$11K ﹤0.01%
200
-42,708
-100% -$2.18M
SNDX icon
2228
Syndax Pharmaceuticals
SNDX
$1.84B
$11K ﹤0.01%
+1,200
New +$11.9K
URGN icon
2229
UroGen Pharma
URGN
$2B
$11K ﹤0.01%
+300
New +$10.7K
SBBP
2230
DELISTED
Strongbridge Biopharma plc.
SBBP
$11K ﹤0.01%
+1,500
New +$9.37K
SIGM
2231
DELISTED
Sigma Designs Inc
SIGM
$11K ﹤0.01%
+1,550
New +$9.71K
VXX
2232
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$11K ﹤0.01%
390
-32,061
-99% -$1.06M
CADE
2233
DELISTED
Cadence Bancorporation
CADE
$11K ﹤0.01%
400
-1,880
-82% -$45.3K
ABEO icon
2234
Abeona Therapeutics
ABEO
$345M
$10K ﹤0.01%
+24
New +$9.93K
ALDX icon
2235
Aldeyra Therapeutics
ALDX
$91.7M
$10K ﹤0.01%
+1,400
New +$9.22K
OCGN icon
2236
Ocugen
OCGN
$410M
$10K ﹤0.01%
+78
New +$9.54K
PSTV icon
2237
Plus Therapeutics
PSTV
$26.4M
– –
0
– –
PTCT icon
2238
PTC Therapeutics
PTCT
$6.37B
$10K ﹤0.01%
600
-4,500
-88% -$76.2K
SITE icon
2239
SiteOne Landscape Supply
SITE
$4.43B
$10K ﹤0.01%
+136
New +$9.21K
VCEL icon
2240
Vericel Corp
VCEL
$2.3B
$10K ﹤0.01%
+1,800
New +$8.3K
EIGR
2241
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$10K ﹤0.01%
+23
New +$8.22K
INFI
2242
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$10K ﹤0.01%
+4,700
New +$9.75K
OTIC
2243
DELISTED
Otonomy, Inc.
OTIC
$10K ﹤0.01%
+1,800
New +$7.82K
SRRA
2244
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$10K ﹤0.01%
+65
New +$6.25K
RARX
2245
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$10K ﹤0.01%
+1,200
New +$14.8K
ABUS icon
2246
Arbutus Biopharma
ABUS
$865M
$9K ﹤0.01%
+1,792
New +$10.5K
BCRX icon
2247
BioCryst Pharmaceuticals
BCRX
$2.37B
$9K ﹤0.01%
+1,800
New +$8.72K
CRBP icon
2248
Corbus Pharmaceuticals
CRBP
$170M
$9K ﹤0.01%
+40
New +$8.56K
ESI icon
2249
Element Solutions
ESI
$9.12B
$9K ﹤0.01%
876
-265,873
-100% -$2.76M
IMNN icon
2250
Imunon
IMNN
$6.35M
$9K ﹤0.01%
+18
New +$10.2K
88 89
90
91 92

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q4 2017 Portfolio in Review

As of Q4 2017, Macquarie Group held 2,531 positions worth $56.6B, up 1.5% from $55.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group's Q4 2017 filing shows 387 new, 823 increased, 1,010 reduced and 163 closed positions. Its largest new stake was WPP: 343,817 shares worth $31.1M. The largest sale was Marathon Oil Corporation, an estimated $149M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q4 2017 buy was WPP: 343,817 shares worth $31.1M.
  • Macquarie Group added most to CME Group in Q4 2017, an estimated $94.6M increase.
  • Macquarie Group's biggest Q4 2017 reduction was Marathon Oil Corporation, cutting an estimated $149M.
  • Macquarie Group fully exited Alexander & Baldwin in Q4 2017, selling an estimated $30.1M.
  • Macquarie Group's ten largest holdings make up 13% of its $56.6B portfolio in Q4 2017.
  • Macquarie Group opened 387 new positions and closed 163 in Q4 2017.
  • Macquarie Group's portfolio value rose 1.5% quarter-over-quarter to $56.6B.

Based on Macquarie Group's 13F filing for Q4 2017, filed 15 Feb 2018.